MarketCapTrends
TVRD

Cara Therapeutics Inc.

NASDAQ · Healthcare

Cara Therapeutics Inc. annual/quarterly net income history and growth rate from 2012 to 2025. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.

  • Cara Therapeutics Inc. net income for the quarter ending March 31, 2025 was -9.6 M, a 127.96% increase year-over-year.
  • Cara Therapeutics Inc. net income for the twelve months ending March 31, 2025 was -26.3 M, a 75.98% decrease year-over-year.
  • Cara Therapeutics Inc. annual net income for 2024 was -29.4 M, a 75.20% decrease from 2023.
  • Cara Therapeutics Inc. annual net income for 2023 was -118.5 M, a 38.65% increase from 2022.
  • Cara Therapeutics Inc. annual net income for 2022 was -85.5 M, a 3.35% decrease from 2021.
  • Cara Therapeutics Inc. annual net income for 2021 was -88.4 M.
Net Income
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %